高危型人HPV感染与前列腺癌的相关性研究进展
|
摘要
高危型人乳头状瘤病毒(human papillomavirus,HPV)的感染与前列腺癌的发生、发展的相关报道日益增多,大量研究发现,HPV感染尤其是高危亚型HPV感染在前列腺癌的发病机制中可能扮演着重要角色。现就近年来高危型HPV感染与前列腺癌的相关研究进展作一综述,为肿瘤病因和发生机制的研究提供新思路。
引文
[1] Colombara D,Auid O,Manhart L,et al. Prior human polyomavirus and papillomavirus infection and incident lung cancer:a nested case-control study[J]. Cancer Causes Control,2015,26(12):1835-1844.
[2]朱皓皞,任光玉,吴琴,等.子宫颈癌中高危型HPV感染与c-jun和c-fos蛋白表达的关系[J].临床与实验病理学杂志,2017,33(1):27-31.
[3]秦豫培,刘鹏,邹灿,等.高危型人乳头瘤状病毒感染与湖北十堰食管鳞癌发生的关系研究[J].现代肿瘤医学,2017,25(22):3610-3612.
[4] Liu C,Li F,Zeng Y,et al. Infection and integration of high-risk human papillomavirus in HPV-associated cancer cells[J]. Med Oncol,2015,32(4):109-112.
[5]郭帅,周政,孙玉峰,等. HPV-16型在前列腺癌人群中的表达及临床意义[J].现代泌尿生殖肿瘤杂志,2017,9(2):95-98.
[6]黄林,吴明贵,何娟,等.高危型人HPV 16/18感染与前列腺癌的相关性研究[J].中华男科学杂志,2016,22(6):501-505.
[7] Anshuma B,Mini P S,Bhavana R. Human papillomavirus-associated cancers:a growing global problem[J]. Int J Appl Basic Med Res,2016,6(2):84-89.
[8] Bosch F X,Broker T R,Forman D,et al. Comprehensive control of human papillomavirus infections and related diseases[J]. Vaccin,2013,22(11):11-31.
[9] Bin Y,Wei L,Pan Y,et al. Association between human papillomavirus and prostate cancer:a meta-analysis[J]. Oncol Lett,2017,14(2):1855-1865.
[10] Pascale M,Pracella D,Barbazza R,et al. Is human papillomavirus associated with prostate cancer survival[J]. Dis Markers,2013,35(6):607-613.
[11] Neha S,Showket H,Nandita K,et al. Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population-apioneering case-control analysis[J]. Sci Rep,2015,16(5):7822-7827.
[12] Fatemeh A,Farokh R Z. Frequency and type distribution of human papilloma virus in patients with prostate cancer[J]. Asian Pac J Cancer Prev,2016,17(8):3953-3958.
[13] Wendy K G,Christopher C N,Timothy G A,et al. High risk human papilloma viruses(HPVs)are present in benign prostate tissues before development of HPV associated prostate cancer[J].Infect Agent Cancer,2017,46(12):1246-1256.
[14] Martha D R,Cesar V M,Anel R A,et al. Human papilloma virus detection by INNOLi PA HPV in prostate tissue from men of northeast mexico[J]. Asian Pac J Cancer Prev,2016,17(11):4863-4865.
[15]吴蒙,孙玉满,汪宏斌,等.下咽鳞状细胞癌中HPV感染、p16表达及其与患者预后的关系[J].临床与实验病理学杂志,2016,32(9):1003-1006
[16]高笫筱,孙俊,章楚光,等.人乳头状瘤病毒与阴茎癌及其癌前病变关系的初步研究[J].中国男科学杂志,2015,29(5):32-35.
[17] Araujo N A,Ferreira F H,Amaral C M,et al. Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil[J]. Genet Mol Biol,2016,39(1):24-29.
[18] Aydin M,Bozkurt A,Cikman A,et al. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer[J]. Int Braz J Urol,2017,43(1):36-46.
[19] Chen A C,Waterboer T,Keleher A,et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients[J]. Pathol Oncol Res,2011,17(3):613-617.
[20] Ehsan G,Seyed H R,Monavari G,et al. Evaluation of human papillomavirus infections in prostatic disease:a cross-sectional study in iran[J]. Asian Pacific J Cancer Prev,2013,14(5):3305-3308.
[21] Suzuki H,Komiya A,Aida S,et al. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer[J]. Prostate,1996,28(5):318-324.
[22] Michopoulou V,Derdas S P,Symvoulakis E,et al. Detection of human papillomavirus(HPV)DNA prevalence and p53 codon 72(Arg72Pro)polymorphism inprostate cancer in a Greek group of patients[J]. Tumour Biol,2014,35(12):12765-12773.
[23] Rogler A,Rogenhofer M,Borchardt A,et al. P53 codon 72(Arg72Pro)polymorphism and prostate cancer risk:association between disease onset and proline genotype[J]. Pathobiology,2011,78(4):193-200.
[24] Anwar K,Nakakuki K,Shiraishi T,et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas[J]. Cancer Res,1992,52(21):5991-5996.
[25] Choo C K,Ling M T,Chan K W,et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames[J]. Prostate,1999,40(3):1580-1588.
[26] Dogra S,Bandi S,Viswanathan P,et al. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma[J]. Cancer Lett,2015,56(2):953-961.
[27] Padash Barmchi M,Gilbert M,Thomas M A,et al. A drosophila model of HPV E6-Induced malignancy reveals essential roles for magi and the insulin receptor[J]. PLo S Pathoq,2016,12(8):e1005789.
[28] Boon S S,Tomai'c V,Thomas M,et al. Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions[J]. J Virol,2015,89(3):1579-1586.
[2]朱皓皞,任光玉,吴琴,等.子宫颈癌中高危型HPV感染与c-jun和c-fos蛋白表达的关系[J].临床与实验病理学杂志,2017,33(1):27-31.
[3]秦豫培,刘鹏,邹灿,等.高危型人乳头瘤状病毒感染与湖北十堰食管鳞癌发生的关系研究[J].现代肿瘤医学,2017,25(22):3610-3612.
[4] Liu C,Li F,Zeng Y,et al. Infection and integration of high-risk human papillomavirus in HPV-associated cancer cells[J]. Med Oncol,2015,32(4):109-112.
[5]郭帅,周政,孙玉峰,等. HPV-16型在前列腺癌人群中的表达及临床意义[J].现代泌尿生殖肿瘤杂志,2017,9(2):95-98.
[6]黄林,吴明贵,何娟,等.高危型人HPV 16/18感染与前列腺癌的相关性研究[J].中华男科学杂志,2016,22(6):501-505.
[7] Anshuma B,Mini P S,Bhavana R. Human papillomavirus-associated cancers:a growing global problem[J]. Int J Appl Basic Med Res,2016,6(2):84-89.
[8] Bosch F X,Broker T R,Forman D,et al. Comprehensive control of human papillomavirus infections and related diseases[J]. Vaccin,2013,22(11):11-31.
[9] Bin Y,Wei L,Pan Y,et al. Association between human papillomavirus and prostate cancer:a meta-analysis[J]. Oncol Lett,2017,14(2):1855-1865.
[10] Pascale M,Pracella D,Barbazza R,et al. Is human papillomavirus associated with prostate cancer survival[J]. Dis Markers,2013,35(6):607-613.
[11] Neha S,Showket H,Nandita K,et al. Implication of high risk human papillomavirus HR-HPV infection in prostate cancer in Indian population-apioneering case-control analysis[J]. Sci Rep,2015,16(5):7822-7827.
[12] Fatemeh A,Farokh R Z. Frequency and type distribution of human papilloma virus in patients with prostate cancer[J]. Asian Pac J Cancer Prev,2016,17(8):3953-3958.
[13] Wendy K G,Christopher C N,Timothy G A,et al. High risk human papilloma viruses(HPVs)are present in benign prostate tissues before development of HPV associated prostate cancer[J].Infect Agent Cancer,2017,46(12):1246-1256.
[14] Martha D R,Cesar V M,Anel R A,et al. Human papilloma virus detection by INNOLi PA HPV in prostate tissue from men of northeast mexico[J]. Asian Pac J Cancer Prev,2016,17(11):4863-4865.
[15]吴蒙,孙玉满,汪宏斌,等.下咽鳞状细胞癌中HPV感染、p16表达及其与患者预后的关系[J].临床与实验病理学杂志,2016,32(9):1003-1006
[16]高笫筱,孙俊,章楚光,等.人乳头状瘤病毒与阴茎癌及其癌前病变关系的初步研究[J].中国男科学杂志,2015,29(5):32-35.
[17] Araujo N A,Ferreira F H,Amaral C M,et al. Lack of detection of human papillomavirus DNA in prostate carcinomas in patients from northeastern Brazil[J]. Genet Mol Biol,2016,39(1):24-29.
[18] Aydin M,Bozkurt A,Cikman A,et al. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer[J]. Int Braz J Urol,2017,43(1):36-46.
[19] Chen A C,Waterboer T,Keleher A,et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients[J]. Pathol Oncol Res,2011,17(3):613-617.
[20] Ehsan G,Seyed H R,Monavari G,et al. Evaluation of human papillomavirus infections in prostatic disease:a cross-sectional study in iran[J]. Asian Pacific J Cancer Prev,2013,14(5):3305-3308.
[21] Suzuki H,Komiya A,Aida S,et al. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer[J]. Prostate,1996,28(5):318-324.
[22] Michopoulou V,Derdas S P,Symvoulakis E,et al. Detection of human papillomavirus(HPV)DNA prevalence and p53 codon 72(Arg72Pro)polymorphism inprostate cancer in a Greek group of patients[J]. Tumour Biol,2014,35(12):12765-12773.
[23] Rogler A,Rogenhofer M,Borchardt A,et al. P53 codon 72(Arg72Pro)polymorphism and prostate cancer risk:association between disease onset and proline genotype[J]. Pathobiology,2011,78(4):193-200.
[24] Anwar K,Nakakuki K,Shiraishi T,et al. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas[J]. Cancer Res,1992,52(21):5991-5996.
[25] Choo C K,Ling M T,Chan K W,et al. Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames[J]. Prostate,1999,40(3):1580-1588.
[26] Dogra S,Bandi S,Viswanathan P,et al. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma[J]. Cancer Lett,2015,56(2):953-961.
[27] Padash Barmchi M,Gilbert M,Thomas M A,et al. A drosophila model of HPV E6-Induced malignancy reveals essential roles for magi and the insulin receptor[J]. PLo S Pathoq,2016,12(8):e1005789.
[28] Boon S S,Tomai'c V,Thomas M,et al. Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions[J]. J Virol,2015,89(3):1579-1586.